VitamFero Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

VitamFero General Information

Description

Developer of anti-infective vaccines intended to offer treatment to the people in France. The company's vaccines are based on a patented technology that designs, develops, registers and commercializes it, enabling physicians to offer remedy against pests of the family Apicomplexa.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8 rue André Le Nôtre
  • 49100 Angers
  • France
+33 02
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 8 rue André Le Nôtre
  • 49100 Angers
  • France
+33 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VitamFero Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 04-Jul-2018 Completed Bankruptcy: Liquidation
4. Grant 20-Jan-2016 Completed Generating Revenue
3. Later Stage VC (Series C) 28-May-2015 Completed Generating Revenue
2. Later Stage VC 22-Feb-2011 $2.04M $2.58M Completed Generating Revenue
1. Seed Round 29-Sep-2009 $535K $535K Completed Startup
To view VitamFero’s complete valuation and funding history, request access »

VitamFero Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA P4
ABSA P4
ABSAP1
Ordinary 1,244 $11.170950 $28.35 $28.35 1x $28.35 0.99%
BSA1 6,618 $11.170950 $28.35 $28.35 1x $28.35 5.25%
To view VitamFero’s complete cap table history, request access »

VitamFero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of anti-infective vaccines intended to offer treatment to the people in France. The company's vaccines are bas
Discovery Tools (Healthcare)
Angers, France
14 As of 2017

South San Francisco, CA
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VitamFero Competitors (5)

One of VitamFero’s 5 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA
Volastra Venture Capital-Backed New York, NY
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
You’re viewing 5 of 5 competitors. Get the full list »

VitamFero Patents

VitamFero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019008272-A1 New attenuated strains of apicomplexa and their use as antigen vectors for the prevention of infectious diseases Inactive 03-Jul-2017
FR-3068364-A1 Use of sarcocystidae strains as multi-combining antigen vectors for the prevention of infectious diseases Inactive 03-Jul-2017
WO-2019008274-A1 Use of sarcocystidae strains as multi-recombinant antigen vectors for the prevention of infectious diseases Inactive 03-Jul-2017
WO-2019008273-A1 Use of strains of sarcocystidae to prevent infectious diseases in poultry Inactive 03-Jul-2017
AU-2015259221-A1 Methods for freeze-drying and rehydrating biologics Active 14-May-2014 A61K39/002
To view VitamFero’s complete patent history, request access »

VitamFero Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VitamFero Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACI Industrie Corporation Minority
To view VitamFero’s complete investors history, request access »

VitamFero FAQs

  • When was VitamFero founded?

    VitamFero was founded in 2005.

  • Where is VitamFero headquartered?

    VitamFero is headquartered in Angers, France.

  • What is the size of VitamFero?

    VitamFero has 14 total employees.

  • What industry is VitamFero in?

    VitamFero’s primary industry is Discovery Tools (Healthcare).

  • Is VitamFero a private or public company?

    VitamFero is a Private company.

  • What is VitamFero’s current revenue?

    The current revenue for VitamFero is .

  • How much funding has VitamFero raised over time?

    VitamFero has raised $7.36M.

  • Who are VitamFero’s investors?

    ACI Industrie has invested in VitamFero.

  • Who are VitamFero’s competitors?

    Genentech, Volastra, Ability Pharma, Gesynta Pharma, and Ona Therapeutics are competitors of VitamFero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process